Cargando…

Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma

Glioblastoma is an aggressive brain tumour with a patient median survival of approximately 14 months. The development of innovative treatment strategies to increase the life span and quality of life of patients is hence essential. This requires the use of appropriate glioblastoma models for preclini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meneceur, Sarah, Linge, Annett, Meinhardt, Matthias, Hering, Sandra, Löck, Steffen, Bütof, Rebecca, Krex, Dietmar, Schackert, Gabriele, Temme, Achim, Baumann, Michael, Krause, Mechthild, von Neubeck, Cläre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226316/ https://www.ncbi.nlm.nih.gov/pubmed/32260145 http://dx.doi.org/10.3390/cancers12040871

Ejemplares similares

Specific requirements for translation of biological research into clinical radiation oncology
por: Krause, Mechthild, et al.
Publicado: (2020)

Heterogeneity of γH2AX Foci Increases in Ex Vivo Biopsies Relative to In Vivo Tumors
por: Rassamegevanon, Treewut, et al.
Publicado: (2018)

Prognostic biomarkers for the response to the radiosensitizer nimorazole combined with RCTx: a pre-clinical trial in HNSCC xenografts
por: Koi, Lydia, et al.
Publicado: (2023)

Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomas
por: Abou-El-Ardat, Khalil, et al.
Publicado: (2017)

Independent validation of tumour volume, cancer stem cell markers and hypoxia-associated gene expressions for HNSCC after primary radiochemotherapy
por: Linge, Annett, et al.
Publicado: (2019)

Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced HNSCC after postoperative radiotherapy
por: Linge, Annett, et al.
Publicado: (2016)

Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme
por: Seidlitz, Annekatrin, et al.
Publicado: (2015)

Orthotopic Glioblastoma Models for Evaluation of the Clinical Target Volume Concept
por: Bütof, Rebecca, et al.
Publicado: (2022)

Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54L
por: Nathansen, Jacqueline, et al.
Publicado: (2021)

Molecular Response to Combined Molecular- and External Radiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Rassamegevanon, Treewut, et al.
Publicado: (2021)

Label-free multiphoton microscopy as a tool to investigate alterations of cerebral aneurysms
por: Sehm, Tina, et al.
Publicado: (2020)

PRONTOX – proton therapy to reduce acute normal tissue toxicity in locally advanced non-small-cell lung carcinomas (NSCLC): study protocol for a randomised controlled trial
por: Zschaeck, Sebastian, et al.
Publicado: (2016)

Molecular Characterization of Astrocytoma Progression Towards Secondary Glioblastomas Utilizing Patient-Matched Tumor Pairs
por: Seifert, Michael, et al.
Publicado: (2020)

RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivo
por: Hendruschk, Sandy, et al.
Publicado: (2011)

NKG2C+ NK Cells for Immunotherapy of Glioblastoma Multiforme
por: Murad, Shafiq, et al.
Publicado: (2022)

A new approach for clinical translation of infrared spectroscopy: exploitation of the signature of glioblastoma for general brain tumor recognition
por: Steiner, Gerald, et al.
Publicado: (2022)

Combined Systemic Drug Treatment with Proton Therapy: Investigations on Patient-Derived Organoids
por: Naumann, Max, et al.
Publicado: (2022)

Exome sequencing identifies frequent genomic loss of TET1 in IDH-wild-type glioblastoma()()
por: Stasik, Sebastian, et al.
Publicado: (2020)

Aurora B Kinase Inhibition by AZD1152 Concomitant with Tumor Treating Fields Is Effective in the Treatment of Cultures from Primary and Recurrent Glioblastomas
por: Krex, Dietmar, et al.
Publicado: (2023)

PORTAF – postoperative radiotherapy of non-small cell lung cancer: accelerated versus conventional fractionation – study protocol for a randomized controlled trial
por: Bütof, R., et al.
Publicado: (2017)

Stability of the CpG island methylator phenotype during glioma progression and identification of methylated loci in secondary glioblastomas
por: Hill, Victoria K, et al.
Publicado: (2014)

Targeted delivery of TLR3 agonist to tumor cells with single chain antibody fragment-conjugated nanoparticles induces type I-interferon response and apoptosis
por: Schau, Isabell, et al.
Publicado: (2019)

Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas
por: Lüttich, Lina, et al.
Publicado: (2021)

Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models
por: Shahzadi, Iram, et al.
Publicado: (2022)

Applying Tissue Slice Culture in Cancer Research—Insights from Preclinical Proton Radiotherapy
por: Suckert, Theresa, et al.
Publicado: (2020)

Targeted Transposition of Minicircle DNA Using Single-Chain Antibody Conjugated Cyclodextrin-Modified Poly (Propylene Imine) Nanocarriers
por: Jugel, Willi, et al.
Publicado: (2022)

Targeted RNAi of BIRC5/Survivin Using Antibody-Conjugated Poly(Propylene Imine)-Based Polyplexes Inhibits Growth of PSCA-Positive Tumors
por: Jugel, Willi, et al.
Publicado: (2021)

Effect of combined irradiation and EGFR/Erb-B inhibition with BIBW 2992 on proliferation and tumour cure in cell lines and xenografts
por: Gurtner, Kristin, et al.
Publicado: (2014)

Sites of recurrent disease and prognostic factors in SCLC patients treated with radiochemotherapy
por: Bütof, Rebecca, et al.
Publicado: (2017)

Retrospective investigation of the prognostic value of the β1 integrin expression in patients with head and neck squamous cell carcinoma receiving primary radio(chemo)therapy
por: Cordes, Nils, et al.
Publicado: (2018)

Late Side Effects in Normal Mouse Brain Tissue After Proton Irradiation
por: Suckert, Theresa, et al.
Publicado: (2021)

Glioblastoma multiforme presenting as postpartum depression: a case report
por: Petzold, Johannes, et al.
Publicado: (2018)

Relative biological effectiveness in proton beam therapy – Current knowledge and future challenges
por: Lühr, Armin, et al.
Publicado: (2018)

Adhesion- and stress-related adaptation of glioma radiochemoresistance is circumvented by β1 integrin/JNK co-targeting
por: Vehlow, Anne, et al.
Publicado: (2017)

Xenograft model of heterotopic transplantation of human ovarian cortical tissue and its clinical relevance
por: Man, Limor, et al.
Publicado: (2022)

The HIV protease and PI3K/Akt inhibitor nelfinavir does not improve the curative effect of fractionated irradiation in PC-3 prostate cancer in vitro and in vivo
por: Liebscher, Steffi, et al.
Publicado: (2017)

Increase in Tumor Control and Normal Tissue Complication Probabilities in Advanced Head-and-Neck Cancer for Dose-Escalated Intensity-Modulated Photon and Proton Therapy
por: Jakobi, Annika, et al.
Publicado: (2015)

GliPR1 knockdown by RNA interference exerts anti‐glioma effects in vitro and in vivo
por: Scheuring, Urban J., et al.
Publicado: (2021)

Longitudinal and Multimodal Radiomics Models for Head and Neck Cancer Outcome Prediction
por: Starke, Sebastian, et al.
Publicado: (2023)

Survivin safeguards chromosome numbers and protects from aneuploidy independently from p53
por: Wiedemuth, Ralf, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_kqs86dtnllphnm40nad86gfhbf